Legal Representation
Attorney
David Toren
USPTO Deadlines
Application History
30 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 19, 2007 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 19, 2007 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Apr 27, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 27, 2007 | EXT4 | S | SOU EXTENSION 4 FILED |
| Apr 27, 2007 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Oct 26, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 26, 2006 | EXT3 | S | SOU EXTENSION 3 FILED |
| Oct 26, 2006 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jul 6, 2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 7, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 7, 2006 | EXT2 | S | SOU EXTENSION 2 FILED |
| Apr 7, 2006 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Apr 7, 2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Oct 19, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 19, 2005 | EXT1 | S | SOU EXTENSION 1 FILED |
| Oct 19, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED |
| May 3, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Feb 8, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 19, 2005 | NPUB | O | NOTICE OF PUBLICATION |
| Dec 10, 2004 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Dec 6, 2004 | ALIE | A | ASSIGNED TO LIE |
| Nov 30, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 30, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
| Jun 23, 2004 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 23, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 15, 2004 | CNFR | O | FINAL REFUSAL MAILED |
| Dec 10, 2003 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Dec 10, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 19, 2003 | CNRT | F | NON-FINAL ACTION MAILED |
| Jun 18, 2003 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
Pharmaceutical and medicinal preparations and substances used in the treatment of heart disease; medicated, dietetic and nutritional preparations, supplements and substances for use in the treatment of heart health, namely, nutritional supplements, dietary supplements; vitamin and mineral supplements for use in the treatment of heart health; medicated chewing gum for use in the treatment of heart health; health-food supplements for use in the treatment of heart health, namely, food supplements, mineral supplements, nutraceuticals for use as a dietary supplement of heart health; medical food preparations for use in the treatment of heart health, namely, food for medically restricted diets; ingredients for use in dietary supplements used for heart health, namely whey protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; dietary supplement drinks used for heart health; nutritional drink mixes for use as a meal replacement for persons with special dietary requirements; nutritional supplements in tablet form derived from milk used to treat heart health; dietary food preparations based on milk used for heart health, namely, meal replacement and dietary supplement drinks
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005